Nov 3, 4:23 PM ET
Innospec reported third-quarter 2026 revenue of $473.6 million, up 7% from $441.9 million a year earlier, and net income attributable to Innospec of $31.8 million, or $1.29 per diluted share, versus $12.9 million, or $0.52, a year earlier. The Board declared a semi-annual dividend of $0.94 per share, bringing the annual dividend to $1.86, a 9% increase over 2025, which shareholders of record as of November 17, 2026 will receive on November 25, 2026.
- Revenue of $473.6 million, up 7% from $441.9 million in the third quarter of 2025.
- GAAP diluted EPS of $1.29 versus $0.52; adjusted non-GAAP EPS of $1.29 versus $1.12.
- Semi-annual dividend of $0.94 per share, payable November 25, 2026; annual dividend of $1.86, up 9%.
- Cash from operating activities of $17.4 million versus $39.1 million a year earlier; cash of $251.9 million and no debt as of September 30, 2026.
Read the filing on SEC.gov ↗
Aug 5, 6:03 AM ET
Innospec reported results for the quarter ended June 30, 2026, with revenue up 12% to $491.4 million and GAAP net income of $30.8 million, or $1.25 per diluted share, compared with $23.5 million, or 94 cents, a year earlier. Adjusted non-GAAP EPS was $1.27 versus $1.26, and the company ended the quarter with $250.2 million in cash and no debt. Operating cash flow was only $7.2 million for the quarter, and the filing does not include formal guidance.
- Revenue of $491.4 million, up 12% from $439.7 million a year earlier
- Net income attributable to Innospec of $30.8 million, or $1.25 per diluted share, versus $1.25 year over year and 94 cents in Q2 2025
- Adjusted non-GAAP EPS of $1.27 versus $1.26; cash from operations of $7.2 million before $16.5 million capital expenditure
- Net cash of $250.2 million with no debt; $6.4 million spent on share repurchases in the quarter
Read the filing on SEC.gov ↗
Jun 4, 4:31 PM ET
Innospec's board increased its size from seven to eight directors and appointed Shelley Bausch as a Class II director effective July 1, 2026, with a seat on the Audit Committee. The filing describes her standard non-employee director pay, which does not involve a change in company results or outlook.
- Board increased from seven to eight directors, effective June 2, 2026
- Shelley Bausch appointed Class II director starting July 1, 2026, serving until the 2027 annual meeting
- Bausch joins the Audit Committee as of July 1, 2026; annual cash retainer of $100,000 plus $5,000 for Audit Committee service
- Expected annual equity grant value of $125,000 in February each year
Read the filing on SEC.gov ↗
May 8, 6:01 AM ET
Innospec reported first-quarter 2026 revenue of $453.2 million, up 3% from a year earlier, but GAAP diluted EPS fell to $1.22 from $1.31 and adjusted EPS fell to $1.05 from $1.42, with Performance Chemicals hit by a January 2026 US winter storm. The Board raised the semi-annual dividend 10% to $0.92 per share and authorized a new $75 million share repurchase program starting May 12, 2026.
- Revenue $453.2 million vs. $440.8 million; Performance Chemicals operating income fell 46% to $10.7 million
- GAAP diluted EPS $1.22 vs. $1.31; adjusted non-GAAP EPS $1.05 vs. $1.42
- Semi-annual dividend of $0.92 per share, up 10%, payable May 29, 2026 to holders of record May 19, 2026
- New $75 million buyback over three years replaces the $50 million authorization, of which about $16 million remained
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.